The determination of polycyclic aromatic hydrocarbons in human urine by high-resolution gas chromatography-mass spectrometry

Biomed Chromatogr. 2018 May;32(5):e4166. doi: 10.1002/bmc.4166. Epub 2018 Jan 16.

Abstract

Polycyclic aromatic hydrocarbons (PAHs), organic compounds formed by at least two condensed aromatic rings, are ubiquitous environmental pollutants that are produced by incomplete combustion of organic materials. PAHs have been classified as carcinogenIC to humans by the International Agency for Research on Cancer, because they can bind to DNA, causing mutations. Therefore, the levels of PAHs in human urine can be used as an indicator for potential carcinogenesis and cell mutation. An analytical method was developed for the accurate measurement of PAHs in urine using high-resolution gas chromatography-mass spectrometry. Urine samples were extracted by an Oasis HLB extraction cartridge after enzymatic hydrolysis with a β-glucuronidase/arylsulfatase cocktail. The 18 PAHs were separated using an Agilent DB-5 MS capillary column (30 m × 0.25 mm, 0.25 μm) and monitored by time-of-flight mass spectrometry. Under the optimized method, the linearity of calibration curves was >0.994. The limits of detection at a signal-to-noise ratio of 3 were 10-100 ng/L. The coefficients of variation were in the range of 0.4-9.0%. The present method was highly accurate for simultaneous determination of 18 PAHs in human urine and could be applied to monitoring and biomedical investigations to check exposure of PAHs.

Keywords: carcinogenesis; gas chromatography; high-resolution mass spectrometry; polycyclic aromatic hydrocarbons; urine.

MeSH terms

  • Female
  • Gas Chromatography-Mass Spectrometry / methods*
  • Humans
  • Limit of Detection
  • Linear Models
  • Male
  • Polycyclic Aromatic Hydrocarbons / urine*
  • Reproducibility of Results

Substances

  • Polycyclic Aromatic Hydrocarbons